Categories: NewsPharmaceutical

Travere Therapeutics to Report Third Quarter 2022 Financial Results

SAN DIEGO, Oct. 20, 2022 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report third quarter 2022 financial results on Thursday, October 27, 2022, after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET.

Conference Call Information

Date: Thursday, October 27, 2022
Time: 4:30 p.m. ET
Dial-in numbers: +1 (888) 394-8218 (U.S.) or +1 (323) 794-2551 (International)
Confirmation code: 3327353
Live webcast: Travere.com in the “Events & Presentations” section of the “Investors” page

A replay of the webcast will be available approximately two hours after the live event and remain archived for approximately 90 days on the Company’s website.

About Travere Therapeutics

At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com

Contact:
Investor Relations
888-969-7879                                        
IR@travere.com

Staff

Recent Posts

CardioComm Solutions Completes Debt Settlement

Toronto, Ontario--(Newsfile Corp. - July 10, 2024) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or…

54 mins ago

ProAssurance to Announce Second Quarter 2024 Results on Thursday, August 8, 2024

Investor call to be held at 10:30 a.m. ET on Friday, August 9BIRMINGHAM, Ala.--(BUSINESS WIRE)--ProAssurance…

3 hours ago

NuGen Announces Proposed Private Placement of up to $10 million Secured Convertible Debentures

Toronto, Ontario--(Newsfile Corp. - July 10, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the…

3 hours ago

Raintree Systems Strengthens C-Suite with Two Executive Appointments

Raintree Names Melissa Markus as Chief Revenue Officer and Chris Farrell as Chief Marketing Officer CHANDLER,…

3 hours ago

Hireology Partners With Activated Insights to Tackle Today’s Healthcare Talent Shortage

CHICAGO, July 10, 2024 /PRNewswire/ -- Hireology, the top-rated applicant tracking system (ATS) built for…

3 hours ago